SEC Filing Analysis: GE HealthCare Technologies Inc. (GEHC)

Executive Summary

• Trading Significance: Low
• Key Takeaway: Director Kevin Lobo received a routine grant of 777 Restricted Stock Units (RSUs).
• Market Impact: Neutral - Standard non-employee director compensation.

Company Information

Field	Value
Company	GE HealthCare Technologies Inc.
Ticker Symbol	GEHC
CIK	0001932393
Industry	X-Ray Apparatus & Tubes

Insider Information

Field	Value
Name	Lobo Kevin
CIK	0001519419
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2026-03-13
Transaction Code	A (Grant)
Security Type	Common Stock
Shares Involved	777
Price Per Share	$0.00
Total Value	$0 (Grant)
Shares Owned After	777
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0 (Estimated market value ~$55k)
% of Market Cap	~0.0002%
Shares Transacted	777
% of Shares Outstanding	0.00017%
Post-Transaction Ownership	777 shares (<0.001% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: With a market cap of $32.25 billion, this grant is immaterial to the stock price.
• Ownership Concentration: The insider holds a negligible percentage of the 455.75 million shares outstanding.
• Dilution Impact: The issuance of 777 shares results in virtually zero dilution to existing shareholders.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: This is a scheduled compensation event for a board member and does not reflect open market sentiment or insider conviction.

Volume & Sentiment

• Expected Volume Impact: None.
• Sentiment Indicator: Neutral.

Additional Context

Transaction Notes

• Vesting Terms: The RSUs vest on the earlier of the next annual meeting or March 13, 2027.
• Deferral: Settlement may be deferred in accordance with the Non-Employee Director Compensation Plan.